A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021

Melanoma and Skin Cancer

Desmoplastic melanoma in Sweden in 2009-2022: A population-based registry study demonstrating distinctive tumour characteristics, incidence and survival trends

J Eur Acad Dermatol Venereol

Girmay Y, Portelli F, Mikiver R, Lapins J, Isaksson K, Helgadottir H

doi: 10.1111/jdv.20522

Melanoma and Skin CancerImmunotherapy

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

J Am Acad Dermatol

Paulson KG, Park SY, Bhatia S, Hippe DS, Nghiem P

doi: 10.1016/j.jaad.2025.03.006

Melanoma and Skin Cancer

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

J Am Acad Dermatol

Andrew TW, Erdmann S, Alrawi M, Plummer R, Shalhout SZ, Sondak V, Brownell I, Lovat PE, Rose A

doi: 10.1016/j.jaad.2024.10.096

Further Publications Immunology

The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis

Clin Epidemiol

Barclay NL, Burkard T, Burn E, Delmestri A, Miquel Dominguez A, Golozar A, Guarner-Argente C, Avilés-Jurado FX, Man WY, Roselló Serrano À, Rosen AW, Tan EH, Tietzova I, Prieto Alhambra D, Newby D, OPTIMA Consortium

doi: 10.2147/CLEP.S463160

Melanoma and Skin Cancer

A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region

J Invest Dermatol

Wei G, Tran MM, Orsillo L, Mirza FN, Yumeen S, Yang E, Robbins A, Mehta A, Liu Z, Vance T, Kawaoka J, Qureshi AA, Wisco OJ

doi: 10.1016/j.jid.2024.04.038

Melanoma and Skin Cancer

Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study

J Eur Acad Dermatol Venereol

Thomas S, Hoyt D, Stoddard G, Snyder AM, Andradottir E, Grant-Kels JM, Ungar J, Lewin JM, Gulati N, Jonasson JG, Sigurdsson H, Helgadottir H, Adalsteinsson JA

doi: 10.1111/jdv.20386

Melanoma and Skin Cancer

Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States

Melanoma Res

Chandrasekaran S, Ling YL, Tang J

doi: 10.1097/CMR.0000000000000990

Psoriasis

Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

Br J Dermatol

Phan DB, Jourdain H, Descalzo-Gallego MA, González-Quesada A, Zureik M, Rivera-Díaz R, Sahuquillo-Torralba A, Lunt M, Garcia-Doval I, Sbidian E, Warren RB, Yiu ZZN

doi: 10.1093/bjd/ljae454

Melanoma and Skin Cancer

Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study

J Eur Acad Dermatol Venereol

Tejera-Vaquerizo A, Gómez-Tomás Á, Jaka A, Toll A, Del Río M, Ferrándiz-Pulido C, Fuente MJ, Carrasco C, Almazán-Fernández FM, Toledo-Pastrana T, Ferrer-Fuertes A, Ribero S, Avallone G, Cañueto J, Santos-Juanes J, Sanmartín O

doi: 10.1111/jdv.20051

Related content

Desmoplastic melanoma in Sweden in 2009-2022: A population-based registry study demonstrating distinctive tumour characteristics, incidence and survival trends

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis

A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region

Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study

Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States

Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study